Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$1.34
-4.0%
$1.98
$0.90
$4.98
$334.82M2.453.86 million shs2.73 million shs
RxSight, Inc. stock logo
RXST
RxSight
$7.19
-7.7%
$11.09
$6.32
$58.23
$292.18M1.161.19 million shs1.66 million shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$3.46
-35.3%
$4.84
$3.10
$9.33
$56.98M1.34142,273 shs1.19 million shs
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$6.13
+7.9%
$5.81
$4.54
$10.79
$385.52M0.68265,786 shs916,488 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
0.00%-5.32%-28.53%-40.13%+44.56%
RxSight, Inc. stock logo
RXST
RxSight
0.00%-7.82%-15.01%-45.24%-84.45%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
0.00%-37.99%-24.45%-22.94%-41.55%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.00%+14.79%-1.29%-10.25%-5.69%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
2.381 of 5 stars
3.41.00.00.02.92.50.6
RxSight, Inc. stock logo
RXST
RxSight
3.1201 of 5 stars
4.04.00.00.01.61.70.6
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.4427 of 5 stars
3.53.00.00.00.80.00.0
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.2751 of 5 stars
3.21.00.00.02.43.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
2.75
Moderate Buy$3.00124.72% Upside
RxSight, Inc. stock logo
RXST
RxSight
1.91
Reduce$10.0039.08% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$9.33169.75% Upside
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
2.33
Hold$9.8360.41% Upside

Current Analyst Ratings Breakdown

Latest SRTS, BFLY, TMCI, and RXST Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/8/2025
RxSight, Inc. stock logo
RXST
RxSight
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$16.00 ➝ $8.00
8/8/2025
RxSight, Inc. stock logo
RXST
RxSight
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$9.00 ➝ $8.00
8/8/2025
RxSight, Inc. stock logo
RXST
RxSight
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$22.00 ➝ $11.00
8/8/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$13.00 ➝ $6.00
8/8/2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$8.60 ➝ $6.50
8/8/2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$9.00 ➝ $6.00
8/4/2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingPositive ➝ Positive$2.00
8/1/2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform
7/15/2025
RxSight, Inc. stock logo
RXST
RxSight
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Equal Weight$20.00 ➝ $9.00
7/10/2025
RxSight, Inc. stock logo
RXST
RxSight
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$24.00 ➝ $9.00
7/9/2025
RxSight, Inc. stock logo
RXST
RxSight
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderperform ➝ Underperform$18.00 ➝ $9.00
(Data available from 8/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
$82.06M4.10N/AN/A$0.92 per share1.45
RxSight, Inc. stock logo
RXST
RxSight
$139.93M2.09N/AN/A$6.98 per share1.03
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.36$0.43 per share8.02$3.41 per share1.01
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
$209.36M1.84N/AN/A$1.81 per share3.39
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$72.49M-$0.28N/AN/AN/A-71.79%-30.53%-21.80%N/A
RxSight, Inc. stock logo
RXST
RxSight
-$27.45M-$0.67N/AN/AN/A-21.93%-11.55%-10.27%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.10N/A15.04N/A-2.26%-1.56%-1.40%N/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$55.74M-$0.85N/AN/AN/A-23.01%-45.66%-23.20%N/A

Latest SRTS, BFLY, TMCI, and RXST Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Guidance Update
RxSight, Inc. stock logo
RXST
RxSight
-$0.04-$0.08-$0.04-$0.29$39.78 million$33.64 million
8/7/2025Q2 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.01-$0.06-$0.07-$0.06$9.30 million$7.32 million
8/7/2025Q2 2025
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
-$0.29-$0.28+$0.01-$0.28$47.08 million$47.39 million
8/1/2025Q2 2025
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
-$0.07-$0.06+$0.01-$0.06$23.91 million$23.38 million
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/AN/AN/AN/AN/A
RxSight, Inc. stock logo
RXST
RxSight
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
N/A
5.68
4.43
RxSight, Inc. stock logo
RXST
RxSight
N/A
12.68
11.65
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.06
5.74
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
0.51
4.50
3.36

Institutional Ownership

CompanyInstitutional Ownership
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
37.85%
RxSight, Inc. stock logo
RXST
RxSight
78.78%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
84.08%

Insider Ownership

CompanyInsider Ownership
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
25.18%
RxSight, Inc. stock logo
RXST
RxSight
9.57%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
27.72%
CompanyEmployeesShares OutstandingFree FloatOptionable
Butterfly Network, Inc. stock logo
BFLY
Butterfly Network
460251.74 million188.35 millionOptionable
RxSight, Inc. stock logo
RXST
RxSight
22040.64 million36.75 millionOptionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable
Treace Medical Concepts, Inc. stock logo
TMCI
Treace Medical Concepts
25062.89 million45.46 millionOptionable

Recent News About These Companies

Treace Medical (TMCI) Q2 Revenue Up 7%
TMCI Treace Medical Concepts, Inc. - Seeking Alpha

New MarketBeat Followers Over Time

Media Sentiment Over Time

Butterfly Network stock logo

Butterfly Network NYSE:BFLY

$1.34 -0.06 (-3.96%)
Closing price 08/8/2025 03:59 PM Eastern
Extended Trading
$1.35 +0.02 (+1.12%)
As of 08/8/2025 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging in a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; and Butterfly iQ+ Vet, a handheld ultrasound system designed for veterinarians. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions to healthcare systems, physicians, and healthcare providers through a direct sales force, distributors, and eCommerce channel. In addition, it offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, and formal education programs through its Butterfly Academy software, as well as professional services for large scale deployments; and ScanLab, an education-only app provides written walkthroughs and reference imagery to guide real-time educational scanning, enhancing the learning process. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

RxSight stock logo

RxSight NASDAQ:RXST

$7.19 -0.60 (-7.70%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$7.19 0.00 (0.00%)
As of 08/8/2025 06:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$3.46 -1.89 (-35.33%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$3.44 -0.02 (-0.43%)
As of 08/8/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Treace Medical Concepts stock logo

Treace Medical Concepts NASDAQ:TMCI

$6.13 +0.45 (+7.92%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$6.14 +0.00 (+0.08%)
As of 08/8/2025 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.